Skip to main content
. Author manuscript; available in PMC: 2016 Jan 1.
Published in final edited form as: Biomaterials. 2014 Oct 12;36:124–133. doi: 10.1016/j.biomaterials.2014.09.017

Figure 3.

Figure 3

Survivin (a), Bcl-2 (b), and P-gp (c) relative expression levels in ovarian cancer cells transfected with NCP-1, NCP-1/siRNAs, NCP-1/sisurvivin, NCP-1/siBcl-2, NCP-1/siP-gp, and Zn control/siRNAs at an siRNA concentration of 30 nM (n=3). (d)-(f) Dose-dependent transfection efficiency mediated by NCP-1/siRNAs and Lipofecatamine RNAiMAX/siRNAs (Lipo/siRNAs) in SKOV-3 cells (n=3).